Keweenaw Financial
KEFI · OTC
About KEFI
- Employees
- 0
- Headquarters
- Hancock, Michigan
- Listed
- Jan 29, 2004
- Sector
- Financials
- Industry
- Banks
KEFI key statistics
- Market cap
- 55.65M
- Price-earnings ratio
- —
- Dividend yield
- 4.17%
- Average volume
- 50
- Volume
- 101
- Open price
- $47.48
- High today
- $47.48
- Low today
- $47.48
- 52 Week high
- $48.50
- 52 Week low
- $48.00
Keweenaw Financial (KEFI) at a glance
Keweenaw Financial (KEFI) last traded at $47.48, with a market cap of 55.65M and a dividend yield of 4.17%.
Volume so far is 101 shares, above the average of 50 shares a day.
Over the past year Keweenaw Financial has ranged from $48.00 to $48.50, and now sits -104% of the way up that range.
Similar companies
Companies in the same industry as Keweenaw Financial
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.